“…Indeed, dropout rates from psychological therapies in PTSD remain a critical barrier to recovery ( Bisson et al, 2013 , Goetter et al, 2015 , Lewis et al, 2020 ). Finally, our EEG-NFB trial remission rates (61.1%) are comparable to those of current, gold standard treatments for PTSD ( Bradley et al, 2005 , Ehring et al, 2014 , van der Kolk et al, 2016 , Rogel et al, 2020 ). Taken together, NFB may represent a valuable adjunctive treatment for PTSD, where it has been suggested previously that NFB may be especially beneficial for PTSD patients experiencing high levels of anxiety, dissociation, and emotion dysregulation related to less optimal response to other forms of trauma-focused therapy ( van der Kolk et al, 2016 , Rogel et al, 2020 ).…”